These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36791627)

  • 1. Quantitation of free cyanide using ion exchange chromatography in Neisseria meningitidis serogroups A, C, W, Y and X conjugates used in vaccine manufacture.
    Ghosh S; Gulhane A; Sharma P; Kale S; Kangralkar V; Pawar R; Goel SK; Mallya AD; Dhere RM
    Biologicals; 2023 Feb; 81():101664. PubMed ID: 36791627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
    Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
    Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
    Cook MC; Bliu A; Kunkel JP
    Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
    Lal G; Balmer P; Joseph H; Dawson M; Borrow R
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of residual sodium dodecyl sulfate in meningococcal polysaccharide by gas chromatography-mass spectrometry.
    Shende N; Karale A; Marathe P; Chakraborty S; Mallya AD; Dhere RM
    Biologicals; 2019 Jul; 60():68-74. PubMed ID: 31126703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.
    Phugare S; Kale S; Sharma P; Kumar Goel S; Gairola S; Jadhav SS
    Vaccine; 2020 Nov; 38(49):7815-7824. PubMed ID: 33164804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
    Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
    Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
    Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
    J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P
    Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of endotoxin by gas chromatography-mass spectrometry in Neisseria meningitidis serogroups A, C, W, Y and X during polysaccharide purification used in conjugate vaccine.
    Shende N; Karale A; Marne K; Deshpande H; Belapurkar H; Mallya AD; Dhere RM
    J Pharm Biomed Anal; 2022 Feb; 209():114536. PubMed ID: 34953414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
    Snape MD; Perrett KP; Ford KJ; John TM; Pace D; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    JAMA; 2008 Jan; 299(2):173-84. PubMed ID: 18182599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.
    Siberry GK; Williams PL; Lujan-Zilbermann J; Warshaw MG; Spector SA; Decker MD; Heckman BE; Demske EF; Read JS; Jean-Philippe P; Kabat W; Nachman S;
    Pediatr Infect Dis J; 2010 May; 29(5):391-6. PubMed ID: 20431379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines.
    Arunachalam AB; Vile S; Rosas A
    Front Immunol; 2022; 13():814088. PubMed ID: 35126397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.
    Gao F; Beresford N; Lockyer K; Burkin K; Rigsby P; Bolgiano B
    Biologicals; 2021 Apr; 70():53-58. PubMed ID: 33518432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.